Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 313-320 , September 2002

High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic control

  • James M. Hempe

      Affiliations

    • Children's Hospital Research Institute for Children, New Orleans, LA, USA
    • Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    • Corresponding Author InformationCorresponding author. Research Institute for Children, 200 Henry Clay Avenue, New Orleans, LA 70118, USA. Tel.: +1-504-896-2707; fax: +1-504-896-9413
    • ,
  • Ricardo Gomez

      Affiliations

    • Children's Hospital Research Institute for Children, New Orleans, LA, USA
    • Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    • ,
  • Robert J. McCarter Jr.

      Affiliations

    • Department of Epidemiology, University of Maryland School of Medicine, Baltimore, MD, USA
    • ,
  • Stuart A. Chalew

      Affiliations

    • Children's Hospital Research Institute for Children, New Orleans, LA, USA
    • Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA

Received 8 October 2001 ,Revised 10 December 2001 ,Accepted 17 December 2001.

References 

  1. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine. 1995;46:223–234
  2. Brownlee M. Negative consequences of glycation. Metabolism: Clinical and Experimental. 2000;49:9–13
  3. Bunn HF, Shapiro R, McManus M, Garrick L, McDonald MJ, Gallop PM, et al. Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. Journal of Biological Chemistry. 1979;254:3892–3898
  4. The Diabetes Control and Complications Trial Research Group. Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care. 1987;10:1–19
  5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  6. Friedman EA. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care. 1999;22(Suppl. 2):B65–B71
  7. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM. Tests of glycemia in diabetes. Diabetes Care. 1995;18:896–909
  8. Gould BJ, Davie SJ, Yudkin JS. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clinica Chimica Acta. 1997;260:49–64
  9. Griffiths WJ, Fitzpatrick M. The effect of age on the creatine in red cells. British Journal of Haematology. 1967;13:175–180
  10. Hempe JM, Craver RD. Quantification of hemoglobin variants by capillary isoelectric focusing. Clinical Chemistry. 1994;40:2288–2295
  11. Hempe JM, Granger JG, Warrier RP, Craver RD. Analysis of hemoglobin variants by capillary isoelectric focusing. Journal of Capillary Electrophoresis. 1997;4:131–135
  12. Hempe JM, Vargas A, Craver RD. Clinical analysis of structural hemoglobin variants and HbA1c by capillary isoelectric focusing. In:  Petersen JR,  Mohammad AA editor. Clinical and forensic applications of capillary electrophoresis. Totowa, NJ: Humana Press; 2001;p. 145–163
  13. Higgins PJ, Bunn HF. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. Journal of Biological Chemistry. 1981;256:5204–5208
  14. Hudson PR, Child DF, Jones H, Williams CP. Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Annals of Clinical Biochemistry. 1999;36:451–459
  15. Kilpatrick ES. Problems in the assessment of glycaemic control in diabetes mellitus. Diabetic Medicine. 1997;14:819–831
  16. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care. 1998;21:261–264
  17. Krishnamurti U, Steffes MW. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clinical Chemistry. 2001;47:1157–1165
  18. Madsen H, Kjaergaard JJ, Ditzel J. Relationship between glycosylation of haemoglobin and the duration of diabetes: a study during the third trimester of pregnancy. Diabetologia. 1982;22:37–40
  19. Murray RL. Creatine. In:  Pesce AJ,  Kaplan LA editor. Methods in clinical chemistry. St. Louis, MO: CV Mosby; 1987;p. 876–881
  20. Peterson KP, Pavlovich JG, Goldstein D, Little R, England J, Peterson CM. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clinical Chemistry. 1998;44:1951–1958
  21. Service FJ, O'Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care. 1987;10:225–237
  22. Shapiro R, McManus MJ, Zalut C, Bunn HF. Sites of nonenzymatic glycosylation of human hemoglobin A. Journal of Biological Chemistry. 1980;255:3120–3127
  23. Turner RC. The UK prospective diabetes study. A review. Diabetes Care. 1998;21(Suppl. 3):C35–C38
  24. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 1990;33:208–215

PII: S1056-8727(01)00227-6

Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 313-320 , September 2002

Article Tools

* Image Usage & Resolution